Blueprint Medicines Corporation (BPMC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Blueprint Medicines Corpo...

NASDAQ: BPMC · Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM

Blueprint Medicines Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
102.01M 71.29M 119.71M 209.95M
Short-Term Investments
513.47M 639.36M 825.28M 267.17M
Long-Term Investments
277.15M 84.32M 161.27M 557.53M
Other Long-Term Assets
59.21M 40.89M 26.78M 19.81M
Receivables
77.61M 43.18M 36.94M 37.03M
Inventory
13.61M 21.22M 29.7M 21.82M
Other Current Assets
35.97M 33.35M 35.02M n/a
Total Current Assets
742.68M 808.39M 1.05B 554.02M
Property-Plant & Equipment
100.77M 115.65M 115.2M 120.86M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
437.13M 240.86M 303.25M 698.2M
Total Assets
1.18B 1.05B 1.35B 1.25B
Account Payables
6.79M 4.71M 2.73M 8.33M
Deferred Revenue
2M 812K 448.62M 36.58M
Short-Term Debt
43.92M 69.48M 16.85M 8.09M
Other Current Liabilities
208.08M 60.9M 31M 84.57M
Total Current Liabilities
260.8M 214.92M 183.23M 149.76M
Long-Term Debt
343.05M 610.96M 122.23M n/a
Other Long-Term Liabilities
277.3M 6.21M 436.97M 3.34M
Total Long-Term Liabilities
620.35M 703.72M 651.99M 131.72M
Total Liabilities
881.15M 918.64M 835.23M 281.49M
Total Debt
469.11M 774.12M 242.45M 111.41M
Book Value
298.67M 130.61M 514.68M 970.74M
Book Value Per Share
4.75 2.16 8.63 16.59
Common Stock
64K 61K 60K 59K
Retained Earnings
-2.41B -2.34B -1.83B -1.28B
Comprehensive Income
-3.55M -3.5M -10.44M -4.13M
Shareholders Equity
298.67M 130.61M 514.68M 970.74M
Total Investments
790.62M 723.67M 958.76M 824.7M